Company profile: Origimm Biotechnology
1.1 - Company Overview
Company description
- Provider of biotechnology research specializing in discovery of antigens and functional drug targets.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Origimm Biotechnology
Newport Labs
HQ: United States
Website
- Description: Provider of veterinary healthcare services and high-quality autogenous biologics for the livestock industry, applying 21st technology to a traditional autogenous approach to formulate products that pinpoint specific disease problems, supported by dedicated employees and innovative solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newport Labs company profile →
ABclonal
HQ: China
Website
- Description: Provider of global antibody and molecular enzyme reagents, offering antibodies for research and diagnostic applications; proteins, peptides, ELISA kits to detect and quantify proteins and other molecules; molecular biology reagents; and next-generation sequencing products and services for genetic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ABclonal company profile →
Cord:Use
HQ: United States
Website
- Description: Provider of cord blood and tissue banking services, preserving umbilical cord stem cells used in treating nearly 80 diseases, and public cord blood donation to build an inventory for patients needing transplants. Offers planned infusion clinics administering cellular therapies under FDA-approved INDs, conducts R&D on treatments for autism and cerebral palsy, and delivers virtual educational seminars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cord:Use company profile →
Remynd
HQ: Belgium
Website
- Description: Provider of investigational programs for CNS protein misfolding disorders, including ReS19-T for Alzheimer’s, ReS18-H for Huntington’s, and ReS3-T for Alzheimer’s and epilepsy, plus a CRO that assesses pharmacokinetics, pharmacodynamics, and efficacy in proprietary animal models, and a phenotypic screening platform to discover small-molecule treatments and novel targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remynd company profile →
Meridian Bioscience
HQ: United States
Website
- Description: Provider of clinical diagnostic test kits, developing, manufacturing, marketing, and distributing assays for gastrointestinal, viral, respiratory, and parasitic infectious diseases, plus bulk antigens and antibodies. Portfolio includes BreathID Smart (H. pylori), Curian, Immunocard STAT!, Premier, Tru, and Merifluor offering rapid immunoassay, enzyme immunoassay, and fluorescent testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridian Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Origimm Biotechnology
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Origimm Biotechnology
2.2 - Growth funds investing in similar companies to Origimm Biotechnology
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Origimm Biotechnology
4.2 - Public trading comparable groups for Origimm Biotechnology
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →